- Home
- GLMD vs MEGL Comparison
GLMD vs MEGL Comparison
Compare GLMD & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- MEGL
- Stock Information
- Founded
- GLMD 2000
- MEGL 2016
- Country
- GLMD Israel
- MEGL Hong Kong
- Employees
- GLMD N/A
- MEGL N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- MEGL Finance: Consumer Services
- Sector
- GLMD Health Care
- MEGL Finance
- Exchange
- GLMD Nasdaq
- MEGL Nasdaq
- Market Cap
- GLMD 7.5M
- MEGL 6.8M
- IPO Year
- GLMD 2014
- MEGL 2022
- Fundamental
- Price
- GLMD $1.51
- MEGL $1.58
- Analyst Decision
- GLMD Hold
- MEGL
- Analyst Count
- GLMD 1
- MEGL 0
- Target Price
- GLMD N/A
- MEGL N/A
- AVG Volume (30 Days)
- GLMD 224.4K
- MEGL 109.6K
- Earning Date
- GLMD 08-28-2025
- MEGL 10-29-2025
- Dividend Yield
- GLMD N/A
- MEGL N/A
- EPS Growth
- GLMD N/A
- MEGL N/A
- EPS
- GLMD N/A
- MEGL N/A
- Revenue
- GLMD N/A
- MEGL $1,645,862.00
- Revenue This Year
- GLMD N/A
- MEGL N/A
- Revenue Next Year
- GLMD N/A
- MEGL N/A
- P/E Ratio
- GLMD N/A
- MEGL N/A
- Revenue Growth
- GLMD N/A
- MEGL N/A
- 52 Week Low
- GLMD $1.15
- MEGL $1.02
- 52 Week High
- GLMD $23.80
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- GLMD 53.20
- MEGL 61.85
- Support Level
- GLMD $1.33
- MEGL $1.30
- Resistance Level
- GLMD $1.63
- MEGL $1.80
- Average True Range (ATR)
- GLMD 0.11
- MEGL 0.13
- MACD
- GLMD 0.03
- MEGL 0.03
- Stochastic Oscillator
- GLMD 69.23
- MEGL 56.00
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.